Cargando…
Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine
Fecal microbiota transplantation (FMT) has demonstrated efficacy in treating inflammatory bowel diseases and irritable bowel syndrome in an increasing number of randomized controlled trials. Recently published data gives striking insights into the factors associated with FMT success paving the road...
Autores principales: | Benech, Nicolas, Sokol, Harry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329555/ https://www.ncbi.nlm.nih.gov/pubmed/32605650 http://dx.doi.org/10.1186/s13073-020-00757-y |
Ejemplares similares
-
Targeting the microbiome: from probiotics to fecal microbiota transplantation
por: Khoruts, Alexander
Publicado: (2018) -
Fecal microbiota transplantation and its potential therapeutic uses in gastrointestinal disorders
por: Heath, Ryan D., et al.
Publicado: (2018) -
Precision medicine and the cursed dimensions
por: Barbour, Dennis L.
Publicado: (2019) -
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel
por: Ianiro, Gianluca, et al.
Publicado: (2020) -
Fecal Microbiota Transplantation as a Tool for Therapeutic Modulation of Non-gastrointestinal Disorders
por: Liptak, Robert, et al.
Publicado: (2021)